Optimal Duration of Oxaliplatin in Adjuvant XELOX for Gastric Cancer Patients (EXODOX)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study aims to compare the efficacy and safety of reduced adjuvant XELOX treatment (4 cycles of XELOX followed by 4 cycles of capecitabine alone) to standard adjuvant XELOX treatment (8 cycles of XELOX).
Epistemonikos ID: 381d512bb8b218c429d4d07995db746ec3d7bbd5
First added on: May 08, 2024